BAM
IDXX icon

Belpointe Asset Management’s Idexx Laboratories IDXX Stock Holding History

Belpointe Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,700
Closed -$818K – 974
2024
Q4 		$818K Buy
+1,700
New +$746K 0.05% 368
2024
Q3 		– Sell
-1,827
Closed -$890K – 959
2024
Q2 		$890K Buy
+1,827
New +$917K 0.06% 302
2023
Q2 		– Sell
-592
Closed -$296K – 1854
2023
Q1 		$296K Buy
592
+36
+6% +$17.2K 0.02% 768
2022
Q4 		$227K Sell
556
-36
-6% -$14K 0.01% 841
2022
Q3 		$193K Buy
592
+85
+17% +$31.2K 0.01% 854
2022
Q2 		$178K Sell
507
-62
-11% -$25.3K 0.01% 869
2022
Q1 		$311K Buy
569
+225
+65% +$118K 0.02% 712
2021
Q4 		$227K Buy
344
+12
+4% +$7.53K 0.01% 845
2021
Q3 		$206K Buy
332
+57
+21% +$38.3K 0.01% 845
2021
Q2 		$173K Sell
275
-1,183
-81% -$653K 0.01% 886
2021
Q1 		$714K Buy
1,458
+1,189
+442% +$596K 0.06% 320
2020
Q4 		$134K Buy
+269
New +$120K 0.01% 842
2020
Q1 		– Sell
-456
Closed -$119K – 700
2019
Q4 		$119K Buy
+456
New +$120K 0.02% 715

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Belpointe Asset Management's IDXX Position: Q1 2025 in Review

Belpointe Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 1,700 shares — an estimated $818K sold.

Belpointe Asset Management first reported a position in IDXX in Q4 2019 and held it in 13 quarters. The position peaked at $890K in Q2 2024. 1,144 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Belpointe Asset Management reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Belpointe Asset Management sold 1,700 Idexx Laboratories shares in Q1 2025, an estimated $818K.
  • Belpointe Asset Management first reported a position in Idexx Laboratories in Q4 2019 and held it in 13 quarters.
  • Belpointe Asset Management's Idexx Laboratories position peaked at $890K in Q2 2024.
  • 1,144 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Belpointe Asset Management's 13F filing for Q1 2025, filed 20 May 2025.